Vol. 13 (2023): 2023-01–12 (Jan to Dec)

EDITORIAL

• ROS 2023 New Focus: Cutting-Edge Research Highlights and Mini-Reviews

  Editorial Office ROS

  e1

  • Full-Text PDF

CUTTING-EDGE RESEARCH HIGHLIGHTS

• 

  Metformin, a “Wonder Drug”, Targets METC for Pulmonary Protection

  Editorial Office ROS

  n1–n3

  • Full-Text PDF
• 

  Redox Signaling in Doxorubicin-Induced Ferroptosis

  Editorial Office ROS

  n4–n6

  • Full-Text PDF
• 

  Nrf1 (NFE2L1) Signaling in Homeostasis: Latest Advances

  Editorial Office ROS

  n7–n9

  • Full-Text PDF
• 

  Nrf2 Signaling in Modulating Pain and Inflammation

  Editorial Office ROS

  n10–n12

  • Full-Text PDF